Lipid peroxidation, circulating cytokine and endothelin 1 levels in healthy volunteers undergoing hyperbaric oxygenation

What Was Tested

The paper reports a study of Endothelin-1, published as a randomized controlled trial.

The aim of the present study was to evaluate the effects of hyperbaric oxygenation on lipid peroxidation, on the release of circulating cytokines (TNFa, IL6, IL1b) and endothelin-1 (ET1).

Who Took Part

According to the abstract, 7 subjects were involved.

The age groups tagged for this paper are adults, both men and women.

Both groups were consecutively pressurized at 2 atmospheres (2 atm abs) and 2.8 atm abs, with a constant descending rate of 1 m/min; in accordance with the experimental design, group A breathed pure oxygen continuously through facial masks and group B breathed chamber air during pressurization.

How the Study Was Run

The design is described as randomized.

Random assignment meant chance, not the researchers, decided who got Endothelin-1 and who got the comparison, which limits bias.

ICU hyperbaric division of a University Hospital.

Twenty millilitres of blood were drawn from all individuals at the following times: 1) basal, before HBO; 2) after 10 min at 2 atm abs; 3) after 10 min at 2.8 atm abs; 4) 30 min after the end of HBO.

In all collected samples thiobarbituric reacting substances were evaluated, using the spectrophotometric technique, IL1 TNF and IL6 serum levels by ELISA and endothelin 1 plasma levels by radioimmunoassay.

What Was Measured

The subject headings attached to it are Cytokines, Endothelin-1, Hyperbaric Oxygenation, Lipid Peroxidation and Thiobarbituric Acid Reactive Substances.

What This Means in Plain Language

The paper is a randomized study of Endothelin-1 in 7 subjects.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The abstract goes on to report its results in about 8 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2001 (Minerva anestesiologica), a journal based in Italy.

More context: the Endothelin-1 compound page, all human trials.